You are using an old and unsupported browser. Most core functionality will not work. Please upgrade to a supported browser - Google Chrome

The Australian and New Zealand Society for Vascular Surgery
The ANZSVS Virtual Scientific Update and AGM
The Australian and New Zealand Society for Vascular Surgery


About Getinge
With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions aiming to improve clinical results and optimise workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.
Getinge offers the Trusted, Reliable, Proven Advanta V12 balloon expandable covered stent which has proven clinical success with over 500 publications, including a Randomised Control Trial now out to 5 years. A recently published Systematic Literature Review of covered balloon expandable (CBE) stents for aorto-iliac occlusive disease highlighted the Advanta V12 as the only balloon-expandable covered stent to have long-term (5 years), real-world follow-up, the results of which were favourable, with a 5 year primary patency rate of 74.7%. 
Furthermore, Getinge provide a wide range of both ePTFE and polyester vascular grafts: Flixene ePTFE AV access grafts, VXT ePTFE peripheral bypass grafts and Hemagard Knitted polyester grafts for open AAA procedures.
Getinge is your valued partner in vascular and endovascular solutions.